Both in Biotechnology
Vaxcyte vs Krystal Biotech
Over the past year PCVX returned +41.5% and KRYS returned +49.6%; their daily moves had a correlation of 0.32.
PCVX +41.5% KRYS +49.6%Growth of $1, one year, split-adjusted
| Metric | PCVX | KRYS |
|---|---|---|
| Price | $60.62 | $295.90 |
| Market cap | $9.54B | $8.76B |
| Today | −2.27% | −10.95% |
| 1 month | +7.3% | −8.2% |
| 6 months | +3.6% | +3.1% |
| Year to date | +31.4% | +20.0% |
| 1 year | +35.5% | +56.5% |
| Revenue growth (YoY) | — | +24.1% |
| Gross margin | — | 94.6% |
| Net margin | — | 45.9% |
| P/E (TTM) | — | 36.3× |
| Price / sales | — | 19.9× |
| Net cash | $1.49B | $845.6M |
| Dividend yield | — | — |
| Volatility (60d) | 70.6% | 38.6% |
| Short % of float | 11.2% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).